SCHEMBL2049998

SCHEMBL2049998

NC(=O)c1cc([N+](=O)[O-])n(C2CC2)n1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.34
CYP3A4 P08684 2/20 0.34
F10 P00742 2/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 2/20 0.33
CTPS1 P17812 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
POLB P06746 1/20 0.33
AR P10275 1/20 0.32
TSHR P16473 2/20 0.31
PIM1 P11309 2/20 0.31
PIM3 Q86V86 2/20 0.31
PIM2 Q9P1W9 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053383 0.94 ALDH1A1 (0.34) SMN1; SMN2CYP3A4F10ALDH1A1MAPT
SCHEMBL21960888 0.76 BAZ2B (0.39) ALDH1A1MAPTPOLB
SCHEMBL27877237 0.76 F10 (0.37) F10ALDH1A1MAPTARPIM1
SCHEMBL6611836 0.74 PLA2G10 (0.43) SMN1; SMN2CYP3A4ALDH1A1TSHRL3MBTL1
SCHEMBL23880197 0.73 OPRM1 (0.35) SMN1; SMN2ALDH1A1MAPTPOLBPIM1
SCHEMBL2794959 0.73 MAP3K14 (0.38) CYP3A4F10ARPIM1PIM3
SCHEMBL27877217 0.70 OPRM1 (0.36) F10ARPIM1PIM3PIM2
SCHEMBL4442669 0.69 L3MBTL1 (0.43) F10ALDH1A1ARPIM1PIM3
SCHEMBL21960853 0.69 LMNA (0.36) SMN1; SMN2CYP3A4ALDH1A1MAPTPOLB
SCHEMBL3500899 0.67 RXRA (0.36) ALDH1A1MAPTPOLBL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516444-A2 HETEROCYCLIC COMPOUNDS AS JANUS KINASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2012-10-31 EP disclosed
CN-102762571-A Heterocyclic compounds as janus kinase inhibitors BIOCRYST PHARM INC 2012-10-31 CN disclosed
WO-2011079230-A2 HETEROCYCLIC COMPOUNDS AS JANUS KINASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2011-06-30 WO disclosed